Here's how much top biotechs spent on R&D last quarter
June 10, 2019 at 06:47 AM EDT
Some of Massachusetts' largest biotechs spent a substantial portion of their first-quarter expenses on R&D — upwards of 75 percent among commercial companies and 87 percent among clinical-stage companies, according to data compiled by the Business Journal.